Pro-Tect buys novel delivery tech patents for pain portffolio
Pro-Tect (PRTT) says new technology patents could drive “revolution” in once-daily drug delivery for pain meds.
Pro-Tect (PRTT) says new technology patents could drive “revolution” in once-daily drug delivery for pain meds.
Norwich Pharmaceuticals is expanding beyond its traditional manufacturing focus by launching a CRO in India to provide clients, and its parent company Alvogen, with clinical research services.
Bill Gates has invested in Schrodinger to support improvements to its drug development software and services.
The WHO has called for recall and destruction of all batches of Indian drugmaker Shantha Biotechnics’ Shan5 vaccine after the discovery of “white sediment” in some vials.
The FDA has issued a letter to stakeholders detailing best practices for preventing and responding to theft of pharma products.
Pfizer will lose patent protection for Viagra in Brazil on June 20 after the Supreme Court (STJ) accepted recommendations by national intellectual property watchdog, the INPI.
CMO Goodwin Biotechnology Inc (GBI) is collaborating with Hyprocell to help clients that need manufacturing services but have a sub-optimal cell line producing low concentrations.